0
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Call for Papers: Beyond Biology: The Crucial Role of Sex and Gender in Oncology

      Submit here before July 31, 2024

      About Oncology Research and Treatment: 2.4 Impact Factor I 3.3 CiteScore I 0.495 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found

      Progredienzangst: Online-Intervention für Brustkrebspatientinnen

      other
      *
      Kompass Onkologie
      S. Karger AG
      fear, psychooncology, psychosocial intervention, anxiety, cancer, cancer survivorship

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective: Fear of cancer recurrence (FCR) is a distressing concern among cancer survivors. Interventions to address FCR need to be effective but also accessible and low cost. This randomized controlled trial evaluated the efficacy of an online group-based psychological intervention for FCR (ConquerFear-Group). Methods: Eligible breast cancer (BC) survivors had completed primary treatment 3 months-5 years previously, were ≥18 years, and scored ≥22 on the Fear of Cancer Recurrence Inventory-Short Form (FCRI-SF). Participants were randomized to online ConquerFear-Group (focusing on metacognitive strategies, values-clarification, and education about follow-up behavior) or online group-based relaxation training (active control). Questionnaires were completed at baseline (T1), 1 week post-intervention (T2), three (T3) and six (T4) months later. The primary outcome was FCR (FCRI total). A number of secondary and process outcomes were also collected. Treatment effects were evaluated with mixed linear models. Results: Of 866 eligible BC survivors, 475 (55%) completed the FCR screening, and 85 (18%) were randomized to ConquerFear-Group or relaxation training (2 × 6 groups). Compared with control participants, ConquerFear-Group participants experienced larger reductions in FCR (Cohen's d = 0.47, p = 0.001) and FCR severity (d = 0.57, p < 0.001), as well as mindfulness and decentering from baseline through follow-up, and improvements in emotion regulation (T2), worry (T2, T3) and rumination (T2) at some time points.

          Related collections

          Author and article information

          Journal
          KKO
          10.1159/issn.2296-5416
          Kompass Onkologie
          Kompass Onkol
          S. Karger AG
          2296-5416
          2296-5386
          2024
          26 April 2024
          : 11
          : 2
          : 82-83
          Affiliations
          [ ]Medizinische Hochschule Hannover, Professur für Psychosomatik und Psychotherapie mit Schwerpunkt Transplantationsmedizin und Onkologie, Hannover, Deutschland
          Author notes
          *Tanja Zimmermann, Zimmermann.Tanja@mh-hannover.de
          Article
          539089 Kompass Onkol 2024;11:82–83
          10.1159/000539089
          131f0d27-2a30-4da4-9b34-817299a9d5d2
          © 2024 S. Karger GmbH, Freiburg
          History
          Page count
          Pages: 2
          Categories
          Wissenstransfer

          Medicine
          psychooncology,cancer,anxiety,psychosocial intervention,cancer survivorship,fear
          Medicine
          psychooncology, cancer, anxiety, psychosocial intervention, cancer survivorship, fear

          Comments

          Comment on this article